Table 1.

Summary of the immunoreactive staining of PELP1 in breast tumors

No stainingPositive stainingNuclear stainingCytoplasmic stainingNuclear and cytoplasmic staining
38.7% (24 of 62)61.3% (38 of 62)2.63% (1 of 38)57.8% (22 of 38)39.5% (15 of 38)